A Study to Assess the Effect of My Happy Flo on Alleviating Period Symptoms and Heavy Flows.
NCT ID: NCT06522672
Last Updated: 2024-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2024-05-31
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Study to Assess the Effect of a Dietary Supplement on Menstrual Cycle Symptoms
NCT07267728
Evaluation of The Cycle SyncingⓇ Method: A 12-Week Virtual Clinical Trial
NCT07286136
Timing of Energy Availability on Menstrual Cycle Function
NCT06471582
A Single Group Study to Evaluate the Effects of a Topical Product on Cramps Associated With the Menstrual Cycle
NCT06939972
The Effect of Menstrual Cycle and Oral Contraceptive Pill Phase on Aspects of Exercise Physiology
NCT05683119
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
My Happy Flo Supplement
Participants will take two capsules of My Happy Flo daily, preferably in the morning with 8-10 oz of water and a meal, for three menstrual cycles.
My Happy Flo
The intervention aims to alleviate period symptoms including heavy flows, prolonged periods, cramps, mood disturbances, energy levels, cycle regulation, and fatigue. Blood tests for Vitamin D and Iron levels will be conducted at Baseline and after the third menstrual cycle. Participants will complete validated questionnaires assessing period symptoms after each menstrual cycle.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
My Happy Flo
The intervention aims to alleviate period symptoms including heavy flows, prolonged periods, cramps, mood disturbances, energy levels, cycle regulation, and fatigue. Blood tests for Vitamin D and Iron levels will be conducted at Baseline and after the third menstrual cycle. Participants will complete validated questionnaires assessing period symptoms after each menstrual cycle.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Experiencing heavy period flows
* Two or more self-reported symptoms (prolonged periods, cramps, poor mood, fatigue, irregular cycle)
* Signs of potential anemia or iron deficiency
* No known allergies to the product ingredients
* Willing to comply with study requirements and limit caffeine intake
* Generally healthy - do not live with any uncontrolled chronic disease
Exclusion Criteria
* A diagnosis of sports anemia within the previous 6 months
* Anyone with known severe allergic reactions that require an Epi-Pen
* Women who are pregnant, breastfeeding, or trying to conceive
* Anyone unwilling to follow the study protocol
* Anyone who has undergone any surgeries or invasive treatments (such as immunotherapy, chemotherapy, radiation, or biological cancer) in the last 30 days or has any planned for the next 12 weeks
* Anyone with a history of substance abuse
* Anyone currently participating or planning to participate in a research study
* Anyone taking prescription anticonvulsants (anti-seizure medications)
* Anyone taking prescription anticoagulant medications (blood thinners)
* Anyone taking any hormone-modulating medications (e.g., hormonal birth control, hormone replacement therapy, testosterone, tamoxifen, thyroid medications, etc.)
* History of hysterectomy, oophorectomy, or other surgery to the reproductive organs
* History of gynecologic cancer, such as cervical, ovarian, uterine, vaginal, or vulvar cancer
* Currently experiencing menopausal or perimenopausal symptoms
* Changes or cessation of hormonal birth control in the last three months
* Active or abnormal uterine/vaginal bleeding
* Resides in RI, NY, NJ, or AZ
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Citruslabs
INDUSTRY
My Happy Flo
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Citruslabs
Santa Monica, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20436
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.